Personal information

Activities

Collapse all

Employment (3)

Institute of Advanced Chemistry of Catalonia: Barcelona, ES

2022-09-01 to present | Juan de la Cierva postdoctoral fellow (Chemical Biology)
Employment
Source: Self-asserted source
Laia Josa-Culleré

Institute of Advanced Chemistry of Catalonia: Barcelona, ES

2019-09-01 to 2022-02-28 | MSCA Individual fellow (Biological Chemistry)
Employment
Source: Self-asserted source
Laia Josa-Culleré

University of Oxford: Oxford, GB

2016-10 to 2019-07-15 | Postdoctoral Fellow
Employment
Source: Self-asserted source
Laia Josa-Culleré

Education and qualifications (2)

University of Oxford: Oxford, GB

2013-10 to 2016-10 | DPhil in Organic Chemistry
Education
Source: Self-asserted source
Laia Josa-Culleré

University of Cambridge: Cambridge, GB

2012-09 to 2013-09 | MPhil in Organic Chemistry
Education
Source: Self-asserted source
Laia Josa-Culleré

Professional activities (1)

Spanish Society of Medicinal Chemistry: Madrid, ES

2018-02-11 to present | Member
Membership
Source: Self-asserted source
Laia Josa-Culleré

Funding (3)

Photoswitching molecules for the spatiotemporal control of cancer stem cells with light

2019-09-01 to 2021-08-31 | Grant
European Commission (Brussels, BE)
URL: https://app.dimensions.ai/details/grant/grant.8585025
GRANT_NUMBER: 841089
Source: Self-asserted source
Laia Josa-Culleré via DimensionsWizard

Oxford Innovative Organic Synthesis for Cancer Research (OxIOSCR)

2013-10 to 2016-09 | Grant
European Commission (Brussels, BE)
Part of GRANT_NUMBER: 316955
Source: Self-asserted source
Laia Josa-Culleré

La Caixa Fellowship for postgraduate studies in Europe

Grant
“la Caixa” Foundation (Barcelona, ES)
Source: Self-asserted source
Laia Josa-Culleré

Peer review (14 reviews for 7 publications/grants)

Review activity for Biomedicines. (1)
Review activity for ChemBioChem. (3)
Review activity for Chemistry. (2)
Review activity for ChemPhotoChem. (2)
Review activity for Journal of medicinal chemistry. (3)
Review activity for Molecules. (1)
Review activity for Pharmaceuticals. (2)
How many people are using ORCID?